This invention relates to methods and devices for physiologic monitoring, pulse oximetry or heart rate monitoring. In particular, the invention relates to photoplethysmography.
Photoplethysmography (PPG) is a technique used in the determination of heart rate and blood oxygen saturation (e.g., pulse oximetry). PPG is often measured using optical detection of a pulsatile change in blood volume in highly-innervated tissues (e.g., fingers, ear lobes). Measuring PPG by optical detection can include illuminating the tissue with typically one wavelength (or two for pulse oximetry) using a light emitter (e.g., a light emitting diode (LED), and measuring the transmission (transmission PPG) or scattering (reflectance PPG) with a photodetector (e.g., photodiode, phototransistor).
PPG and pulse oximetry measurements are susceptible to motion artifacts. Minute movements of the light emitter and/or sensor with respect to the tissue will introduce artifacts which can render extraction of the underlying signal difficult, and can corrupt the calculation of the oxygen saturation value.
Various aspects of the present disclosure are directed toward such above-discussed and other apparatuses and methods for interfacing with a patient.
Consistent with certain exemplary embodiments, the disclosure describes apparatuses and methods that utilize two circuits operative for contacting highly-innervated tissue (e.g., the skin surface of a person or patient) with one of the circuits illuminating tissue at the surface by sending light toward the surface. A circuit-enclosure, or housing, is used to contact the skin surface of the patient with light provided by the first circuit being characterized in a first wavelength range. The first circuit also senses a PPG signal of the patient in response to the light being sent toward the surface. The second circuit senses artifacts due to surface motion, where such artifacts are attributable to contact-based surface motion at a portion of the housing that is in contact with the skin surface of the patient. The frequency range of the artifacts overlaps with the frequency range of the PPG sensed by the first wavelength and/or as affecting the light in the first frequency range. Further, the second circuit responds to the sensed PPG signal by processing the sensed PPG signal relative to the sensed artifacts to produce a version of the sensed PPG signal that is indicative of local blood volume and blood composition of the patient. The PPG signal indicative of local blood volume and blood composition of the patient is filtered by the second circuit to suppress noise therein due to the contact-based surface motion.
Other aspects of the disclosure are directed to related embodiments in which the contact is not necessarily effecting direct engagement between the housing and the skin. In one such embodiment, the second circuit includes an impedance-based sensor that measures the surface motion artifacts, and the second circuit senses artifacts attributable to indirect contact-based surface motion at a portion of the housing in response to the housing being in sufficient proximity of the skin surface to transfer energy between the skin surface and the impedance-based sensor.
The above summary is not intended to describe each embodiment or every implementation of the present disclosure. The figures, detailed description and claims that follow more particularly exemplify various embodiments.
Aspects of the present disclosure may be more completely understood in consideration of the detailed description of various embodiments of the present disclosure that follows in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the scope of the disclosure including aspects defined in the claims.
The present disclosure is believed to be useful for applications involving devices, apparatuses, and methods that determine local blood volume and blood composition in a subject and mitigate motion-induced errors that can occur during measurement. For instance, various aspects of the present disclosure are directed toward mitigation of artifacts in PPG signals due to the subtle movements of the devices/apparatuses (sensors), which are in same frequency range as the PPG signal itself, with respect to the tissue. Such sensors, consistent with various aspects of the present disclosure, can include structure that allows for placement of a patient's finger for determining local blood volume and blood composition. For instance, a patient will place his or her finger in, on, or near the sensor for PPG measurements. Based on the skin surface movements, motion defects occurs, and are determined/measured based on the surface movements. Accordingly, various aspects of the present disclosure include determination of at least one noise reference signal indicative of the artifacts that negatively affect the PPG signal(s) that is used to adaptively filter the PPG signal(s) to provide an accurate determination of PPG and/or a pulse oximetry measurement of a patient.
Various aspects of the present disclosure are directed toward apparatuses and methods for interfacing with a patient. The apparatus and methods are directed towards the apparatus operative for contacting the skin surface of the patient with one of the circuits illuminating tissue at the surface by sending light toward the surface. For example, the apparatus includes a housing for enclosing at least a first one of the circuits that contacts the skin surface of the patient, where the first circuit illuminates tissue at the surface by sending light toward the surface. Such contact at the skin surface is implemented in certain embodiments by a near contact and in other embodiments by an actual contact. The light provided by the first circuit is characterized as being in a first wavelength range. The first circuit also senses a PPG signal of the patient in response to the light being sent toward the surface.
The apparatus and methods for interfacing with a patient also include a second circuit that senses artifacts due to surface motion. In certain embodiments, the artifacts are characterized in that the artifact frequency range overlaps with the frequency range of the PPG sensed by the first wavelength and/or as affecting the light in the first frequency range. Further, the second circuit responds to the sensed PPG signal by processing the sensed PPG signal relative to the sensed artifacts to produce a version of the sensed PPG signal that is indicative of local blood volume and blood composition (e.g., heart rate or blood oxygen saturation) of the patient. The sensed PPG signal is filtered by the second circuit to suppress noise therein due to the surface motion.
In certain embodiments, the second circuit includes an impedance-based sensor that is used to measure the surface motion artifacts. In certain more specific embodiments, the impedance-based sensor determines electrical properties of the skin surface. Certain embodiments of the present disclosure are characterized in that the second circuit sends light toward the surface. The light sent by the second circuit is a second wavelength range that is different than the first wavelength range (sent by the first circuit). Additionally, in certain embodiments, the second circuit can include both an impedance-based sensor that measures surface motion artifacts of the patient that are both physiological and mechanical, and the second circuit that illuminates tissue at the surface at a second wavelength. In these such embodiments, the second circuit measures transmitted or reflected light being characterized by a second wavelength range and, in response thereto, measures physiological and mechanical surface motion artifacts of the patient and produce the filtered version of the sensed PPG signal.
Additionally, other embodiments, consistent with various aspects of the present disclosure are characterized in that the second circuit having an impedance-based sensor, which includes capacitance circuit and a computer that is electrically coupled to the capacitance circuitry. In such an embodiment, the impedance-based sensor measures physiological and mechanical surface motion artifacts of the patient. Further, the computer measures physiological and mechanical surface motion artifacts of the patient and produces the filtered version of the sensed PPG signal. In certain embodiments, the second circuit measures a transmitted or reflected PPG signal. Additionally, the second circuit can generate a noise-reference signal based on the sensed artifacts. The noise-reference signal is being characterized to correlate predominantly with the artifacts and minimally to the sensed PPG signal.
Various aspects of the present disclosure are also directed toward methods of interfacing with a patient. In such methods, the skin surface of the patient is contacted, and a light source is used to illuminate tissue at the surface, which sends light (in a first wavelength range) toward the surface. Additionally, a PPG signal of the patient is sensed in response to the light being sent toward the surface. Further, artifacts are sensed due to surface motion. The artifacts are characterized as also being in the first wavelength range, and in response to the sensed PPG signal, the sensed PPG signal is processed relative to the sensed artifacts to produce a version of the sensed PPG signal that is indicative of local blood volume and blood composition of the patient as filtered to suppress noise therein due to the surface motion.
Turning now to the Figures,
The motion reference block 110 passes the signal representing the artifacts (Signal 2) through a filter block 116. Additionally, a signal (Signal 1) representing the noisy PPG is passed from the noisy PPG block 100. Signals 1 and 2 are provided to a processor block 120. The processor block 120 responds to the PPG signal (Signal 1) by processing the sensed PPG signal relative to the sensed artifacts (Signal 2) to produce a filter version, represented by filtered PPG block 125, of the sensed PPG signal that is indicative of local blood volume and blood composition of the patient. The filtered version of the sensed PPG signal is shown in the inset graph 130. The filtered PPG block 125 suppresses the noise due to the surface motion.
Red/IR light emitters also can have good transmission of these wavelengths through the tissue, which increases the signal in transmission mode and allows the interrogation of deep arteries. These wavelengths have low scattering coefficients. On the other hand, shorter wavelengths (yellow, green) have higher absorption coefficients as well as higher scattering coefficients. While detrimental for transmission mode (not enough light passes through the finger/ear lobe), this absorption generates more signal for reflectance mode. It also can sense more superficially. Successful reflectance mode PPG sensors have been constructed with green LEDs.
The skin of the finger 400, in response to light shown thereon by the second light source 415, has a distinct wavelength dependence for both absorption and scattering. The wavelength of the second light source 415 is absorbed only at the surface of the skin (where the remaining capillaries show much attenuated pulsation). Due to the wavelength of the second light source 415 being absorbed only at the surface of the skin, the reflectance of the light from the second light source 415 measured at the photo detector 410 is indicative of motion artifacts at the surface. For instance, the upper graphs 420 of
Such an arrangement can utilize a photodetector, a light emitter (e.g., LED), and a second light emitter having an emission spectrum located close to the first light emitter (e.g., IR, red or green). In this manner due to the differing wavelength dependence for both absorption and scattering, a PPG signal is collected, and a separate optically-based signal is collected that captures the motion artifact due to sensor/tissue movements, but not the pulse signal. The wavelength of interest for such surface sensing would be in the blue/near-UV (as opposed to the red/IR wavelengths for a PPG signal), based on the strong adsorption of the melanin pigment present in the epidermis. Reducing the intensity of the emitted light will also contribute to a more superficial sensing, containing less of the pulsatile component.
Accordingly, because of the wavelength dependence of both absorption and scattering, a wavelength for a second light emitter can be selected which is absorbed only at the surface of the skin, where the remaining capillaries show much attenuated pulsation. The optically-based noise reference signal then becomes mainly a function of how the light is coupled into the skin, and where it is measured.
Further, as noted in
As discussed herein, in measuring the PPG signal of a patient, the motion artifacts are determined when the patient's skin surface (e.g., digit/member) makes direct contact or medium-intervening contact in which the contact is indirect as indicated via with an impedance-based sensor. The impedance-based sensor can include or be implemented as part of a capacitive-touch apparatus such as a pulse oximeter or a smart tablet (e.g., smartphone) that also includes a camera and a light source. For instance, a patient can place his or her finger on the sensing-surface of the sensor (including circuitry as discussed herein) or a patient can place his or her finger for near contact (e.g., as would occur when energy is transferred between a capacitively-charged surface and a finger situated apart from one another by one to several millimeters). The capacitance circuitry, as described above, has sensitivity such that it can sense near contact of the patient. Further, in embodiments that use a second light source in mitigation of motion negatively affecting the PPG signal, light for both the PPG and the mitigation of motion can be provided from the sensor or smart tablet toward the skin surface. A camera (as is provided with the sensor or smart tablet) that is sensitive to both wavelengths can determine the motion artifacts based on wavelengths reflected/scattered at the skin surface (motion reference) versus wavelength absorbed more deeply and reflecting a stronger PPG signal, as presented for contact situations. The camera can measure the reflected/scattered light from the finger irrespective of the distance away from the finger (the angle of the light source(s) is not a significant factor).
Accordingly, in the above-discussed embodiments, the second circuit includes an impedance-based (e.g., capacitor-based) sensor that measures the surface motion artifacts attributable to contact-based surface motion at a portion of the housing when the housing is in sufficient proximity of the skin surface to transfer energy between the skin surface and the impedance-based sensor.
In each of
In certain instances, an optically-based noise reference signal can be sensed at both sides of tissue of a finger if transmission mode is performed. Further, an electrically-based noise reference signal can also utilize an impedance measurement, rather than a pure capacitance measurement. Such an impedance measurement can be performed by direct measurement of the impedance with metal contact surrounding the sensor. Because of the high impedance of the skin, such signals will also be very sensitive to skin/sensor contact, and therefore sensitive to relative motion. For all modes of electrical sensing, the sensor could be unique or composed of several sensitive surfaces.
For further discussion of physiologic monitoring, pulse oximetry or heart rate monitoring and mitigating motion artifacts of the measurement as relating to the embodiments and specific applications discussed herein, reference may be made to the underlying U.S. Provisional Patent Application, Ser. No. 61/693,270 filed on Aug. 25, 2012 (including the Appendix therein) to which priority is claimed. The aspects discussed therein may be implemented in connection with one or more of embodiments and implementations of the present disclosure (as well as with those shown in the figures). Moreover, for general information and for specifics regarding applications and implementations to which one or more embodiments of the present disclosure may be directed to and/or applicable, reference may be made to the references cited in the aforesaid patent application and published article, which are fully incorporated herein by reference generally and for the reasons noted above. In view of the description herein, those skilled in the art will recognize that many changes may be made thereto without departing from the spirit and scope of the present disclosure.
Various circuit-based building blocks and/or other modules may be implemented to carry out one or more of the operations and activities described herein and/or shown in the Figures. In such contexts, a “block” or “module” is a circuit that carries out one or more of these or related operations/activities. For example, in certain of the above-discussed embodiments, one or more blocks are discrete logic circuits or programmable logic circuits configured and arranged for implementing these operations/activities, as in the circuit modules shown in the Figures, such as the filter block or processor block shown in
Based upon the above discussion and illustrations, those skilled in the art will readily recognize that various modifications and changes may be made without strictly following the exemplary embodiments and applications illustrated and described herein. Furthermore, various features of the different embodiments may be implemented in various combinations. Such modifications do not depart from the true spirit and scope of the present disclosure, including those set forth in the following claims.
Number | Name | Date | Kind |
---|---|---|---|
5040539 | Schmitt et al. | Aug 1991 | A |
5111817 | Clark et al. | May 1992 | A |
5450846 | Goldreyer | Sep 1995 | A |
5672875 | Block et al. | Sep 1997 | A |
5792998 | Gardner, Jr. et al. | Aug 1998 | A |
5859652 | Silverbrook | Jan 1999 | A |
5909227 | Silverbrook | Jun 1999 | A |
6010836 | Eichorst et al. | Jan 2000 | A |
6064065 | Block et al. | May 2000 | A |
6139819 | Unger et al. | Oct 2000 | A |
6169914 | Hovland et al. | Jan 2001 | B1 |
6231834 | Unger et al. | May 2001 | B1 |
6261236 | Grimblatov | Jul 2001 | B1 |
6380294 | Babinec et al. | Apr 2002 | B1 |
6408198 | Hanna et al. | Jun 2002 | B1 |
6420709 | Block et al. | Jul 2002 | B1 |
6431173 | Hoffmann | Aug 2002 | B1 |
6491647 | Bridger et al. | Dec 2002 | B1 |
6521211 | Unger et al. | Feb 2003 | B1 |
6535754 | Fishbein et al. | Mar 2003 | B2 |
6549801 | Chen et al. | Apr 2003 | B1 |
6586520 | Canorro et al. | Jul 2003 | B1 |
6699199 | Asada et al. | Mar 2004 | B2 |
6707257 | Norris | Mar 2004 | B2 |
6731967 | Turcott | May 2004 | B1 |
6754535 | Noren et al. | Jun 2004 | B2 |
6839585 | Lowery et al. | Jan 2005 | B2 |
6905470 | Lee et al. | Jun 2005 | B2 |
6997879 | Turcott | Feb 2006 | B1 |
7020507 | Scharf et al. | Mar 2006 | B2 |
7058272 | Bourdelais et al. | Jun 2006 | B2 |
7130689 | Turcott | Oct 2006 | B1 |
7194306 | Turcott | Mar 2007 | B1 |
7254425 | Lowery et al. | Aug 2007 | B2 |
7277741 | Debreczeny et al. | Oct 2007 | B2 |
7288584 | Highcock et al. | Oct 2007 | B2 |
7300166 | Agrawal et al. | Nov 2007 | B2 |
7329402 | Unger et al. | Feb 2008 | B2 |
7452551 | Unger et al. | Nov 2008 | B1 |
7477924 | Chin | Jan 2009 | B2 |
7483731 | Hoarau et al. | Jan 2009 | B2 |
7486979 | Matlock | Feb 2009 | B2 |
7499740 | Nordstrom et al. | Mar 2009 | B2 |
7507579 | Boccazzi et al. | Mar 2009 | B2 |
7515949 | Norris | Apr 2009 | B2 |
7519413 | Morris et al. | Apr 2009 | B1 |
7522948 | Chin | Apr 2009 | B2 |
7545903 | Kohler et al. | Jun 2009 | B2 |
7555327 | Matlock | Jun 2009 | B2 |
7574244 | Eghbal et al. | Aug 2009 | B2 |
7574245 | Arizaga Ballesteros | Aug 2009 | B2 |
7590439 | Raridan et al. | Sep 2009 | B2 |
7629400 | Hyman | Dec 2009 | B2 |
7641614 | Asada et al. | Jan 2010 | B2 |
7647084 | Eghbal et al. | Jan 2010 | B2 |
7650177 | Hoarau et al. | Jan 2010 | B2 |
7657294 | Eghbal et al. | Feb 2010 | B2 |
7657295 | Coakley et al. | Feb 2010 | B2 |
7657296 | Raridan et al. | Feb 2010 | B2 |
7674230 | Reisfeld | Mar 2010 | B2 |
7676253 | Raridan, Jr. | Mar 2010 | B2 |
7684842 | Ollerdessen | Mar 2010 | B2 |
7684843 | Coakley et al. | Mar 2010 | B2 |
7691067 | Westbrook et al. | Apr 2010 | B2 |
7693559 | Raridan et al. | Apr 2010 | B2 |
7712673 | Jones | May 2010 | B2 |
7720516 | Chin et al. | May 2010 | B2 |
7725146 | Li et al. | May 2010 | B2 |
7725147 | Li et al. | May 2010 | B2 |
7725187 | Nabutovsky et al. | May 2010 | B1 |
7727159 | Choi et al. | Jun 2010 | B2 |
7728048 | Labrec | Jun 2010 | B2 |
7729736 | Raridan, Jr. | Jun 2010 | B2 |
7738155 | Agrawal | Jun 2010 | B2 |
7738935 | Turcott | Jun 2010 | B1 |
7738937 | Coakley et al. | Jun 2010 | B2 |
7756580 | Turcott | Jul 2010 | B1 |
7787946 | Stahmann et al. | Aug 2010 | B2 |
7789311 | Jones et al. | Sep 2010 | B2 |
7794406 | Reisfeld et al. | Sep 2010 | B2 |
7796403 | Coakley | Sep 2010 | B2 |
7803118 | Reisfeld et al. | Sep 2010 | B2 |
7803119 | Reisfeld | Sep 2010 | B2 |
7824029 | Jones et al. | Nov 2010 | B2 |
7839416 | Ebensberger et al. | Nov 2010 | B2 |
7839417 | Ebensberger et al. | Nov 2010 | B2 |
7857768 | Starr et al. | Dec 2010 | B2 |
7869849 | Ollerdessen et al. | Jan 2011 | B2 |
7869850 | Hoarau et al. | Jan 2011 | B2 |
7879564 | Brice et al. | Feb 2011 | B2 |
7881762 | Kling et al. | Feb 2011 | B2 |
7894869 | Hoarau | Feb 2011 | B2 |
7899510 | Hoarau | Mar 2011 | B2 |
7904130 | Raridan, Jr. | Mar 2011 | B2 |
7907809 | Korampally et al. | Mar 2011 | B2 |
7912672 | Feichtinger et al. | Mar 2011 | B2 |
7920919 | Nabutovsky | Apr 2011 | B1 |
7924972 | Koehler et al. | Apr 2011 | B2 |
7929220 | Sayag | Apr 2011 | B2 |
7980596 | Labrec | Jul 2011 | B2 |
7998080 | Ben-Ari et al. | Aug 2011 | B2 |
8034898 | Caravan et al. | Oct 2011 | B2 |
8060171 | Hoarau et al. | Nov 2011 | B2 |
8073516 | Scharf et al. | Dec 2011 | B2 |
8073518 | Chin | Dec 2011 | B2 |
8093062 | Winger | Jan 2012 | B2 |
8095192 | Baker, Jr. | Jan 2012 | B2 |
8140143 | Picard et al. | Mar 2012 | B2 |
8145288 | Baker, Jr. | Mar 2012 | B2 |
8152732 | Lynn et al. | Apr 2012 | B2 |
8157730 | LeBoeuf et al. | Apr 2012 | B2 |
8162841 | Keel et al. | Apr 2012 | B2 |
8175670 | Baker, Jr. et al. | May 2012 | B2 |
8175671 | Hoarau | May 2012 | B2 |
8190224 | Hoarau | May 2012 | B2 |
8190225 | Hoarau | May 2012 | B2 |
8195263 | Drebreczeny et al. | Jun 2012 | B2 |
8195264 | Hoarau | Jun 2012 | B2 |
8204567 | Petersen | Jun 2012 | B2 |
8204786 | LeBoeuf et al. | Jun 2012 | B2 |
20020183611 | Fishbein et al. | Dec 2002 | A1 |
20030139667 | Hewko et al. | Jul 2003 | A1 |
20030166998 | Lowery et al. | Sep 2003 | A1 |
20030208239 | Lu | Nov 2003 | A1 |
20030212336 | Lee et al. | Nov 2003 | A1 |
20030225337 | Scharf et al. | Dec 2003 | A1 |
20040030230 | Norris | Feb 2004 | A1 |
20040147832 | Fishbein et al. | Jul 2004 | A1 |
20050038349 | Choi et al. | Feb 2005 | A1 |
20050043608 | Haj-Yousef | Feb 2005 | A1 |
20050054939 | Ben-Ari et al. | Mar 2005 | A1 |
20050165316 | Lowery et al. | Jul 2005 | A1 |
20050192488 | Bryenton et al. | Sep 2005 | A1 |
20050203357 | Debreczeny et al. | Sep 2005 | A1 |
20050209516 | Fraden | Sep 2005 | A1 |
20050243053 | Liess | Nov 2005 | A1 |
20060047214 | Fraden | Mar 2006 | A1 |
20060211930 | Scharf et al. | Sep 2006 | A1 |
20060264755 | Maltz et al. | Nov 2006 | A1 |
20070004977 | Norris | Jan 2007 | A1 |
20070053482 | Kohler et al. | Mar 2007 | A1 |
20070055163 | Asada et al. | Mar 2007 | A1 |
20070070800 | Virag et al. | Mar 2007 | A1 |
20070106137 | Baker, Jr. et al. | May 2007 | A1 |
20070167844 | Asada et al. | Jul 2007 | A1 |
20070213619 | Linder | Sep 2007 | A1 |
20070213620 | Reisfeld | Sep 2007 | A1 |
20070213621 | Reisfeld et al. | Sep 2007 | A1 |
20070213622 | Reisfeld | Sep 2007 | A1 |
20070213624 | Reisfeld et al. | Sep 2007 | A1 |
20070244399 | Kim et al. | Oct 2007 | A1 |
20080009690 | Debreczeny et al. | Jan 2008 | A1 |
20080081961 | Westbrook et al. | Apr 2008 | A1 |
20080132798 | Hong et al. | Jun 2008 | A1 |
20080133171 | Feichtinger et al. | Jun 2008 | A1 |
20080146892 | Le Boeuf et al. | Jun 2008 | A1 |
20080190430 | Melker et al. | Aug 2008 | A1 |
20080200787 | Shapira et al. | Aug 2008 | A1 |
20080238695 | Yanai | Oct 2008 | A1 |
20080287815 | Chon et al. | Nov 2008 | A1 |
20090043179 | Melker et al. | Feb 2009 | A1 |
20090054752 | Jonnalagadda et al. | Feb 2009 | A1 |
20090105556 | Fricke et al. | Apr 2009 | A1 |
20090118598 | Hoarau | May 2009 | A1 |
20090203998 | Klinghult | Aug 2009 | A1 |
20090209834 | Fine | Aug 2009 | A1 |
20090221888 | Wijesiriwardana | Sep 2009 | A1 |
20090227853 | Wijesiriwardana | Sep 2009 | A1 |
20090227965 | Wijesiriwardana | Sep 2009 | A1 |
20090232379 | Kohler et al. | Sep 2009 | A1 |
20090281399 | Keel et al. | Nov 2009 | A1 |
20090281435 | Ahmed et al. | Nov 2009 | A1 |
20090292193 | Wijesiriwardana | Nov 2009 | A1 |
20090326351 | Addison et al. | Dec 2009 | A1 |
20100004517 | Bryenton et al. | Jan 2010 | A1 |
20100016691 | Watson et al. | Jan 2010 | A1 |
20100079279 | Watson et al. | Apr 2010 | A1 |
20100094147 | Inan et al. | Apr 2010 | A1 |
20100145201 | Westbrook et al. | Jun 2010 | A1 |
20100160794 | Banet et al. | Jun 2010 | A1 |
20100160795 | Banet et al. | Jun 2010 | A1 |
20100160796 | Banet et al. | Jun 2010 | A1 |
20100160797 | Banet et al. | Jun 2010 | A1 |
20100160798 | Banet et al. | Jun 2010 | A1 |
20100168589 | Banet et al. | Jul 2010 | A1 |
20100168596 | Jaeschke et al. | Jul 2010 | A1 |
20100192952 | Melker et al. | Aug 2010 | A1 |
20100217099 | LeBoeuf et al. | Aug 2010 | A1 |
20100217102 | LeBoeuf | Aug 2010 | A1 |
20100241186 | Turcott | Sep 2010 | A1 |
20100268056 | Ricard et al. | Oct 2010 | A1 |
20100312131 | Naware et al. | Dec 2010 | A1 |
20100331715 | Addison et al. | Dec 2010 | A1 |
20110004072 | Fletcher et al. | Jan 2011 | A1 |
20110009754 | Wenzel et al. | Jan 2011 | A1 |
20110009755 | Wenzel et al. | Jan 2011 | A1 |
20110040345 | Wenzel et al. | Feb 2011 | A1 |
20110046498 | Klap et al. | Feb 2011 | A1 |
20110054279 | Reisfeld et al. | Mar 2011 | A1 |
20110066041 | Pandia et al. | Mar 2011 | A1 |
20110066042 | Pandia et al. | Mar 2011 | A1 |
20110066381 | Garudadri et al. | Mar 2011 | A1 |
20110071366 | McKenna | Mar 2011 | A1 |
20110082355 | Eisen et al. | Apr 2011 | A1 |
20110098112 | LeBoeuf et al. | Apr 2011 | A1 |
20110098583 | Pandia et al. | Apr 2011 | A1 |
20110106627 | LeBoeuf et al. | May 2011 | A1 |
20110112442 | Meger et al. | May 2011 | A1 |
20110125208 | Karst et al. | May 2011 | A1 |
20110144460 | Oh et al. | Jun 2011 | A1 |
20110144461 | Oh et al. | Jun 2011 | A1 |
20110172504 | Wegerich | Jul 2011 | A1 |
20110184297 | Vitali et al. | Jul 2011 | A1 |
20110224518 | Tindi et al. | Sep 2011 | A1 |
20110245633 | Goldberg et al. | Oct 2011 | A1 |
20110251503 | Ben-Ari et al. | Oct 2011 | A1 |
20110257489 | Banet et al. | Oct 2011 | A1 |
20110257551 | Banet et al. | Oct 2011 | A1 |
20110257552 | Banet et al. | Oct 2011 | A1 |
20110257553 | Banet et al. | Oct 2011 | A1 |
20110257554 | Banet et al. | Oct 2011 | A1 |
20110257555 | Banet et al. | Oct 2011 | A1 |
20110301436 | Teixeira | Dec 2011 | A1 |
20120022336 | Teixeira | Jan 2012 | A1 |
20120022350 | Teixeira | Jan 2012 | A1 |
20120022384 | Teixeira | Jan 2012 | A1 |
20120022844 | Teixeira | Jan 2012 | A1 |
20120065527 | Gill et al. | Mar 2012 | A1 |
20120065528 | Gill et al. | Mar 2012 | A1 |
20120078066 | Ahmed et al. | Mar 2012 | A1 |
20120078119 | Ahmed et al. | Mar 2012 | A1 |
20120078120 | Ahmed et al. | Mar 2012 | A1 |
20120078130 | Ahmed et al. | Mar 2012 | A1 |
20120078321 | Blomqvist et al. | Mar 2012 | A1 |
20120108928 | Tverskoy | May 2012 | A1 |
20130303922 | Buchheim | Nov 2013 | A1 |
Number | Date | Country |
---|---|---|
WO 2011029029 | Mar 2011 | WO |
WO 2013052574 | Apr 2013 | WO |
Entry |
---|
H. Tandri et al. “Reversible Cardiac Conduction Block and Defibrillation with High-Frequency Electric Field.” Sci Transl Med 3(102), Sep. 28, 2011, 16 pgs. |
M. Z. Poh et al. “Non-contact, automated cardiac pulse measurements using video imaging and blind source separation.” Optics Express 18(10), May 2010, pp. 10762-10774. |
Number | Date | Country | |
---|---|---|---|
20140058217 A1 | Feb 2014 | US |
Number | Date | Country | |
---|---|---|---|
61693270 | Aug 2012 | US |